Los Angeles Capital Management’s Cardlytics CDLX Stock Holding History

Los Angeles Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,411	Closed	-$80.3K	–	1355
2025 Q1	$80.3K	Buy	+4,411	New	+$126K	﹤0.01%	1069
2024 Q2	–	Sell	-10,692	Closed	-$1.55M	–	1184
2024 Q1	$1.55M	Buy	10,692 +2,837	+36%	+$240K	0.01%	558
2023 Q4	$723K	Buy	7,855 +5,178	+193%	+$526K	﹤0.01%	779
2023 Q3	$442K	Buy	+2,677	New	+$348K	﹤0.01%	852
2021 Q3	–	Sell	-615	Closed	-$780K	–	1481
2021 Q2	$780K	Buy	615 +224	+57%	+$253K	﹤0.01%	961
2021 Q1	$428K	Buy	+391	New	+$516K	﹤0.01%	1282
2020 Q3	–	Sell	-334	Closed	-$234K	–	1441
2020 Q2	$234K	Buy	+334	New	+$193K	﹤0.01%	1356

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Los Angeles Capital Management's CDLX Position: Q2 2025 in Review

Los Angeles Capital Management sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 4,411 shares — an estimated $80.3K sold.

Los Angeles Capital Management first reported a position in CDLX in Q2 2020 and held it in 7 quarters. The position peaked at $1.55M in Q1 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

Los Angeles Capital Management reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
Los Angeles Capital Management sold 4,411 Cardlytics shares in Q2 2025, an estimated $80.3K.
Los Angeles Capital Management first reported a position in Cardlytics in Q2 2020 and held it in 7 quarters.
Los Angeles Capital Management's Cardlytics position peaked at $1.55M in Q1 2024.
89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.